Georgiamune
Georgiamune Inc. is a Gaithersburg, Maryland based biopharmaceutical company developing first-in-class immunotherapies that reprogram immune signaling pathways to rebalance the immune system and restore health across cancer and autoimmune diseases. Built on a target-discovery platform, its pipeline of immunomodulators spans clinical, preclinical, and discovery stages, including the clinical-stage dual-functioning antibody GIM-122, the regulatory T-cell (Treg) inhibitor GIM-531, and the Treg activator GIM-407, alongside additional antibody and small-molecule programs. The company was surfaced as a venture-backed portfolio company and profiled in the API Evangelist network; it does not currently publish a public API, developer portal, or programmatic interface.
Georgiamune is profiled on the APIs.io network. Tagged areas include Company, Biopharmaceutical, Immunotherapy, Oncology, and Autoimmune.
Georgiamune’s developer surface includes engineering blog and 2 more developer resources.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Access & Security 1
Authentication, authorization, and security posture
Company 2
The organization behind the API